Weight gain after starting HIV treatment may have genetic influences
HIV-positive people with fatty liver disease are at high risk for fibrosis
Child with HIV maintains viral suppression for three years off treatment
Diagnostic challenges with PrEP use during early HIV infection
New approaches for paediatric dosing: abacavir in newborns, doubling dolutegravir with rifampicin
New mothers with HIV gain more weight on dolutegravir than efavirenz
Immune modulator clears pre-cancerous anal lesions
Black MSM are 60% less likely to have suppressed HIV than white men in Atlanta
Yes, the same life expectancy as HIV-negative people, but far fewer years in good health